Tamoxifen citrate
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Tamoxifen citrate Product Information
Tamoxifen citrate is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Tamoxifen. The product is supplied by Clearsynth under CAT No. CS-O-31029.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Tamoxifen citrate
CAS No.
54965-24-1
CAT No.
CS-O-31029
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C32H37NO8
Molecular Weight
563.64
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Tamoxifen citrate is supplied with detailed characterization data compliant with regulatory guideline. Tamoxifen citrate can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Tamoxifen.
Overview
" Tamoxifen Citrate is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4."
Synonyms
Tamoxifen citrate
Application Notes
" Tamoxifen Citrate is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.